Stevens-Johnson Syndrome in a Patient on Concomitant Treatment with Levetiracetam and Trimethoprim/Sulfamethoxazole

Amel Tabet Aoul; Abraheim Al-Nasseri; Chase Hall; Chun He; John Abernathy

doi:10.12659/AJCR.942982

22 January 2024 : Case report USA

Stevens-Johnson Syndrome in a Patient on Concomitant Treatment with Levetiracetam and Trimethoprim/Sulfamethoxazole

Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Adverse events of drug therapy, Clinical situation which can not be reproduced for ethical reasons

Amel Tabet Aoul^1ABDEF*, Abraheim Al-Nasseri^1E, Chase Hall^1E, Chun He^2D, John Abernathy^3E

DOI: 10.12659/AJCR.942982

Am J Case Rep 2024; 25:e942982

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 2. Skin punch biopsy specimen showing necrotic keratinocytes, full-thickness epidermal necrosis, and epidermo-dermal junction separation, accompanied by neutrophils and lymphocytes dermal infiltrate.

Back to the Article

Stevens-Johnson Syndrome in a Patient on Concomitant Treatment with Levetiracetam and Trimethoprim/Sulfamethoxazole

Your Privacy